← Back to the feed

AKENZA AG

History from 8 Jun 2017

UID

CHE-202.142.764

Legal form

AG

Canton

ZH

Founded

8 Jun 2017

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 2 Nov 2018 · legal date 9 Oct 2018

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   100’000 → 200’000

   Shares

   1’000 → 2’000’000

   New shares, % of post-step shares

   — (nominal value per share changed)

   Aktienkapital neu: CHF 200'000.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 200'000.00 [bisher: CHF 100'000.00]. Aktien neu: 2'000'000 Namenaktien zu CHF 0.10 [bisher: 1'000 Inhaberaktien zu CHF 100.00]. Vinkulierung neu: Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

   SHAB HR02-1004489207 ↗

2. SHAB published 22 Aug 2019 · legal date 13 Aug 2019

   Name changed

   Hivemind AG → AKENZA AG

   SHAB HR02-1004700224 ↗

3. SHAB published 14 Jul 2020 · legal date 2 Jul 2020

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   200’000 → 325’714.20

   Shares

   2’000’000 → 3’257’142

   New shares, % of post-step shares

   38.6% (1’257’142 new)

   Aktienkapital neu: CHF 325'714.20 [bisher: CHF 200'000.00]. Liberierung Aktienkapital neu: CHF 325'714.20 [bisher: CHF 200'000.00]. Aktien neu: 3'257'142 Namenaktien zu CHF 0.10 [bisher: 2'000'000 Namenaktien zu CHF 0.10].

   SHAB HR02-1004936034 ↗

4. SHAB published 6 Sep 2021 · legal date 26 Aug 2021

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   325’714.20 → 414’285.60

   Shares

   3’257’142 → 4’142’856

   New shares, % of post-step shares

   21.4% (885’714 new)

   Aktienkapital neu: CHF 414'285.60 [bisher: CHF 325'714.20]. Liberierung Aktienkapital neu: CHF 414'285.60 [bisher: CHF 325'714.20]. Aktien neu: 4'142'856 Namenaktien zu CHF 0.10 [bisher: 3'257'142 Namenaktien zu CHF 0.10].

   SHAB HR02-1005284343 ↗

5. SHAB published 21 Jun 2022 · legal date 9 Jun 2022

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   414’285.60 → 525’488.60

   Shares

   4’142’856 → 5’254’886

   New shares, % of post-step shares

   21.2% (1’112’030 new)

   Aktienkapital neu: CHF 525'488.60 [bisher: CHF 414'285.60]. Liberierung Aktienkapital neu: CHF 525'488.60 [bisher: CHF 414'285.60]. Aktien neu: 5'254'886 Namenaktien zu CHF 0.10 [bisher: 4'142'856 Namenaktien zu CHF 0.10].

   SHAB HR02-1005500202 ↗

6. SHAB published 13 Nov 2025 · legal date 7 Nov 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   525’488.60 → 774’083.10

   Shares

   5’254’886 → 7’740’831

   New shares, % of post-step shares

   32.1% (2’485’945 new)

   Aktienkapital neu: CHF 774'083.10 [bisher: CHF 525'488.60]. Liberierung Aktienkapital neu: CHF 774'083.10 [bisher: CHF 525'488.60]. Aktien neu: 7'740'831 Namenaktien zu CHF 0.10 [bisher: 5'254'886 Namenaktien zu CHF 0.10].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.72 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006483316 ↗

Published by 16 Nov 2025

Latest available record · 8 Oct 2026